Grants / Department of Defense / Defense Health Agency Contracting Activity - DHACA

W81XWH-22-PRCRP-IA: DoD Peer Reviewed, Idea Award

Closed Closed September 7, 2022 Opportunity W81XWH-22-PRCRP-IA ☆ Save

This grant is closed. A newer notice from the same program is open now: DoW Breast Cancer, Clinical Research Extension Award (HT942526BCRPCREA2). Status: Closes November 18, 2026 (11 days left). It is in our archive of Defense Health Agency Contracting Activity - DHACA notices from 2022.

• Total funding$22.4 million
• Expected awards35
• Cost sharingNot required
• Funding typeCooperative Agreement, Grant

Key dates

Who can apply

This opportunity was open to any type of organization.

• Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Most of the program's money (59% over five years) went to colleges and universities.
• No cost sharing or match is required.

What the grant funds

The FY22 PRCRP Idea Award supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods in cancer research that are relevant to active-duty Service Members, Veterans, other military beneficiaries, and the American public. Cancers or circumstances with cancer risk that may affect the Service Members’ support system (military families) are of special importance. The advancement of knowledge in cancer research, patient care, and/or treatment options in the Military Health System (MHS) is critical to active-duty Service Members, Veterans, other military beneficiaries, and the American public. The intention of the Idea Award is innovative research that may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. The Idea Award is not intended to support a logical progression of an already established research project in a laboratory. Incremental advances, the next logical step, or switching a model system from one cancer to another cancer are not considered innovative. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. It is the responsibility of the Principal Investigator (PI) to select the funding opportunity that is most appropriate for the research proposed. Advanced research with robust preliminary data is more appropriate for the FY22 PRCRP Impact Award (W81XWH-22-PRCRP-IPA).

Category: Science and Technology and other Research and Development.

Applying now

This notice no longer takes applications. Apply under the newer notice, HT942526BCRPCREA2, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.